• Provides technical and analytical expertise for late phase biologics process development and commercial manufacturing activities for multiple technology areas (e.g. cell banking, cell culture, purification, formulation, or bioconjugation) • Responsible for managing projects in multiple technological areas at external CDMO partners • Acts as the Biologics lead for a specific therapeutic program • Communicates with cross-functional teams in formal settings and third-party meetings • Supports the international roll-out of approved prostate cancer imaging agent and helps advance portfolio of late clinical-stage products